CU104

· Curacle Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CU104, covering 2023-06-18 to 2023-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis [Phase 2]